نتائج البحث - "Denise A, Yardley"

1

Academic Journal

Supplemental Table 3 from Intrinsic Subtype and Overall Survival of Patients with Advanced HR + /HER2 − Breast Cancer Treated with Ribociclib and ET: Correlative Analysis of MONALEESA-2, -3, -7

المؤلفون: Aleix Prat, Nadia Solovieff, Fabrice André, Joyce O'Shaughnessy, David A. Cameron, Wolfgang Janni, Gabe S. Sonke, Yoon-Sim Yap, Denise A. Yardley, Ann H. Partridge, Astrid Thuerigen, Juan Pablo Zarate, Agnes Lteif, Fei Su, Lisa A. Carey

مصطلحات موضوعية: Cancer, Cancer Detection and Diagnosis, Clinical Research and Trials, Biomarkers, Prognostic biomarkers, Breast Cancer, Clinical Trial Results, Phase III clinical trials

Relation: https://figshare.com/articles/journal_contribution/Supplemental_Table_3_from_Intrinsic_Subtype_and_Overall_Survival_of_Patients_with_Advanced_HR_sup_sup_HER2_sup_sup_Breast_Cancer_Treated_with_Ribociclib_and_ET_Correlative_Analysis_of_MONALEESA-2_-3_-7/25232383

الاتاحة: https://doi.org/10.1158/1078-0432.25232383.v1

View record in BASE

2

Academic Journal

Supplemental Table 2 from Intrinsic Subtype and Overall Survival of Patients with Advanced HR + /HER2 − Breast Cancer Treated with Ribociclib and ET: Correlative Analysis of MONALEESA-2, -3, -7

المؤلفون: Aleix Prat, Nadia Solovieff, Fabrice André, Joyce O'Shaughnessy, David A. Cameron, Wolfgang Janni, Gabe S. Sonke, Yoon-Sim Yap, Denise A. Yardley, Ann H. Partridge, Astrid Thuerigen, Juan Pablo Zarate, Agnes Lteif, Fei Su, Lisa A. Carey

مصطلحات موضوعية: Cancer, Cancer Detection and Diagnosis, Clinical Research and Trials, Biomarkers, Prognostic biomarkers, Breast Cancer, Clinical Trial Results, Phase III clinical trials

Relation: https://figshare.com/articles/journal_contribution/Supplemental_Table_2_from_Intrinsic_Subtype_and_Overall_Survival_of_Patients_with_Advanced_HR_sup_sup_HER2_sup_sup_Breast_Cancer_Treated_with_Ribociclib_and_ET_Correlative_Analysis_of_MONALEESA-2_-3_-7/25232386

الاتاحة: https://doi.org/10.1158/1078-0432.25232386.v1

View record in BASE

3

Academic Journal

Supplemental Table 1 from Intrinsic Subtype and Overall Survival of Patients with Advanced HR + /HER2 − Breast Cancer Treated with Ribociclib and ET: Correlative Analysis of MONALEESA-2, -3, -7

المؤلفون: Aleix Prat, Nadia Solovieff, Fabrice André, Joyce O'Shaughnessy, David A. Cameron, Wolfgang Janni, Gabe S. Sonke, Yoon-Sim Yap, Denise A. Yardley, Ann H. Partridge, Astrid Thuerigen, Juan Pablo Zarate, Agnes Lteif, Fei Su, Lisa A. Carey

مصطلحات موضوعية: Cancer, Cancer Detection and Diagnosis, Clinical Research and Trials, Biomarkers, Prognostic biomarkers, Breast Cancer, Clinical Trial Results, Phase III clinical trials

Relation: https://figshare.com/articles/journal_contribution/Supplemental_Table_1_from_Intrinsic_Subtype_and_Overall_Survival_of_Patients_with_Advanced_HR_sup_sup_HER2_sup_sup_Breast_Cancer_Treated_with_Ribociclib_and_ET_Correlative_Analysis_of_MONALEESA-2_-3_-7/25232389

الاتاحة: https://doi.org/10.1158/1078-0432.25232389.v1

View record in BASE

4

Academic Journal

Supplemental Figure 1 from Intrinsic Subtype and Overall Survival of Patients with Advanced HR + /HER2 − Breast Cancer Treated with Ribociclib and ET: Correlative Analysis of MONALEESA-2, -3, -7

المؤلفون: Aleix Prat, Nadia Solovieff, Fabrice André, Joyce O'Shaughnessy, David A. Cameron, Wolfgang Janni, Gabe S. Sonke, Yoon-Sim Yap, Denise A. Yardley, Ann H. Partridge, Astrid Thuerigen, Juan Pablo Zarate, Agnes Lteif, Fei Su, Lisa A. Carey

مصطلحات موضوعية: Cancer, Cancer Detection and Diagnosis, Clinical Research and Trials, Biomarkers, Prognostic biomarkers, Breast Cancer, Clinical Trial Results, Phase III clinical trials

Relation: https://figshare.com/articles/journal_contribution/Supplemental_Figure_1_from_Intrinsic_Subtype_and_Overall_Survival_of_Patients_with_Advanced_HR_sup_sup_HER2_sup_sup_Breast_Cancer_Treated_with_Ribociclib_and_ET_Correlative_Analysis_of_MONALEESA-2_-3_-7/25232392

الاتاحة: https://doi.org/10.1158/1078-0432.25232392.v1

View record in BASE

5

Academic Journal

Matching-adjusted indirect comparison of PFS and OS comparing ribociclib plus letrozole palbociclib plus letrozole as first-line treatment of HR+/HER2− advanced breast cancer

المؤلفون: Komal Jhaveri, Joyce O’Shaughnessy, Peter A. Fasching, Sara M. Tolaney, Denise A. Yardley, Vikash Kumar Sharma, Chandroday Biswas, Astrid Thuerigen, Purnima Pathak, Hope S. Rugo

المصدر: Therapeutic Advances in Medical Oncology, Vol 15 (2023)

مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1758-8359

URL الوصول: https://doaj.org/article/f9fa04a73b63440b97588ebecf3c53a7

View record in DOAJ

Full Text Finder

6

Academic Journal

Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapy endocrine therapy alone in patients with HR+/HER2− early breast cancer

المصدر: Therapeutic Advances in Medical Oncology, Vol 15 (2023)

مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1758-8359

URL الوصول: https://doaj.org/article/73d02bee3f9e4dc6a76bef48c3ed8ce0

View record in DOAJ

Full Text Finder

7

Academic Journal

Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033): a randomized controlled trial

المؤلفون: Romualdo Barroso-Sousa, Paolo Tarantino, Nabihah Tayob, Chau Dang, Denise A. Yardley, Steven J. Isakoff, Vicente Valero, Meredith Faggen, Therese Mulvey, Ron Bose, Jiani Hu, Douglas Weckstein, Antonio C. Wolff, Katherine Reeder-Hayes, Hope S. Rugo, Bhuvaneswari Ramaswamy, Dan Zuckerman, Lowell Hart, Vijayakrishna K. Gadi, Michael Constantine, Kit Cheng, Frederick Briccetti, Bryan Schneider, Audrey Merrill Garrett, Kelly Marcom, Kathy Albain, Patricia DeFusco, Nadine Tung, Blair Ardman, Rita Nanda, Rachel C. Jankowitz, Mothaffar Rimawi, Vandana Abramson, Paula R. Pohlmann, Catherine Van Poznak, Andres Forero-Torres, Minetta Liu, Kathryn J. Ruddy, Yue Zheng, Shoshana M. Rosenberg, Richard D. Gelber, Lorenzo Trippa, William Barry, Michelle DeMeo, Harold Burstein, Ann Partridge, Eric P. Winer, Ian Krop, Sara M. Tolaney

المصدر: npj Breast Cancer, Vol 8, Iss 1, Pp 1-7 (2022)

مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2374-4677

URL الوصول: https://doaj.org/article/e88fcc1488804534afd42026e28dc869

View record in DOAJ

Full Text Finder

8

Academic Journal

Glembatumumab vedotin for patients with metastatic, gpNMB overexpressing, triple-negative breast cancer ('METRIC'): a randomized multicenter study

المؤلفون: Linda T. Vahdat, Peter Schmid, Andres Forero-Torres, Kimberly Blackwell, Melinda L. Telli, Michelle Melisko, Volker Möbus, Javier Cortes, Alberto J. Montero, Cynthia Ma, Rita Nanda, Gail S. Wright, Yi He, Thomas Hawthorne, Rebecca G. Bagley, Abdel-Baset Halim, Christopher D. Turner, Denise A. Yardley

المصدر: npj Breast Cancer, Vol 7, Iss 1, Pp 1-10 (2021)

مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2374-4677

URL الوصول: https://doaj.org/article/17180d15d53a444b97cb83ce78fb7480

View record in DOAJ

Full Text Finder

9

Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial

المصدر: The Lancet Oncology. 24:273-285

مصطلحات موضوعية: Oncology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::f44b54dbee330cc4378e80a16fc9c58c
https://doi.org/10.1016/s1470-2045(23)00051-7

View record in OpenAIRE

10

Supplementary Fig. S1 from Impact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with Pertuzumab

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e8aedc7b8facd30ae5fdfd8dec38a2a
https://doi.org/10.1158/2159-8290.22538948

View record in OpenAIRE

11

Supplementary Table S2 from Impact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with Pertuzumab

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70029c4a13c0e215d7eb9c8e6691c2bd
https://doi.org/10.1158/2159-8290.22538927

View record in OpenAIRE

12

Data from Impact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with Pertuzumab

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a398926894d3f2961bea956ef7d118f7
https://doi.org/10.1158/2159-8290.c.6548945

View record in OpenAIRE

13

Supplementary Table S2 from Clinical and Translational Results of a Phase II, Randomized Trial of an Anti–IGF-1R (Cixutumumab) in Women with Breast Cancer That Progressed on Endocrine Therapy

المؤلفون: Paul Haluska, Dmitri Grebennik, Jan Cosaert, Tuan S. Nguyen, Amelie Forest, Ruslan Novosiadly, Shande Tang, Hagop Youssoufian, Gary N. Schwartz, Donald W. Northfelt, Ellen Chuang, Joseph A. Sparano, Rachel Layman, Denise A. Yardley, William J. Gradishar

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::222c1f489d77cbb5804e0f9132e213dc
https://doi.org/10.1158/1078-0432.22458794

View record in OpenAIRE

14

Data from Central Nervous System Metastasis in Patients with HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from SystHERs

المؤلفون: Melody Cobleigh, Vincent Antao, Haocheng Li, Laura Chu, Debu Tripathy, Peter A. Kaufman, Sandra M. Swain, Hope S. Rugo, Adam Brufsky, Mohammad Jahanzeb, Denise A. Yardley, Ginny Mason, Joyce O'Shaughnessy, Sara A. Hurvitz

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5390a0f43a131a3169a90e8e31c17288
https://doi.org/10.1158/1078-0432.c.6528281

View record in OpenAIRE

15

Supplemental Figures from MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2− Metastatic Breast Cancer

المؤلفون: José Baselga, Andrew Koustenis, Martin Frenzel, Denise A. Yardley, Esther Zamora, Joyce O'Shaughnessy, Clifford A. Hudis, Hans Wildiers, Debra Patt, Véronique Diéras, Javier Cortés, Hope S. Rugo, Sara M. Tolaney, Maura N. Dickler

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c79c5a83b7a7daad1f4634068fd8b447
https://doi.org/10.1158/1078-0432.22468395

View record in OpenAIRE

16

Supplemental Table from MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2− Metastatic Breast Cancer

المؤلفون: José Baselga, Andrew Koustenis, Martin Frenzel, Denise A. Yardley, Esther Zamora, Joyce O'Shaughnessy, Clifford A. Hudis, Hans Wildiers, Debra Patt, Véronique Diéras, Javier Cortés, Hope S. Rugo, Sara M. Tolaney, Maura N. Dickler

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9935dfa4ebd65bb05f8542cd874cec7
https://doi.org/10.1158/1078-0432.22468389

View record in OpenAIRE

17

Supplementary Tables 1-3 from A Phase I/Ib Study of Enzalutamide Alone and in Combination with Endocrine Therapies in Women with Advanced Breast Cancer

المؤلفون: Tiffany A. Traina, Jacqueline A. Gibbons, Joyce L. Steinberg, Martha E. Blaney, Amy C. Peterson, Ayca Gucalp, Howard A. Burris, Patricia LoRusso, Manish Patel, Anthony D. Elias, Denise A. Yardley, Lee S. Schwartzberg

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a62e2551fc74e7f53ee96ef6c332331
https://doi.org/10.1158/1078-0432.22469238.v1

View record in OpenAIRE

18

Supplemental Figure 2 from A Phase I/Ib Study of Enzalutamide Alone and in Combination with Endocrine Therapies in Women with Advanced Breast Cancer

المؤلفون: Tiffany A. Traina, Jacqueline A. Gibbons, Joyce L. Steinberg, Martha E. Blaney, Amy C. Peterson, Ayca Gucalp, Howard A. Burris, Patricia LoRusso, Manish Patel, Anthony D. Elias, Denise A. Yardley, Lee S. Schwartzberg

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d70d9e002241c22eda9837f3a8e3ea8e
https://doi.org/10.1158/1078-0432.22469244.v1

View record in OpenAIRE

19

Supplementary Table from Phase I/II Trial of Exemestane, Ribociclib, and Everolimus in Women with HR+/HER2− Advanced Breast Cancer after Progression on CDK4/6 Inhibitors (TRINITI-1)

المؤلفون: Stacy Moulder, Das Purkayastha, Hope S. Rugo, Cynthia Ma, Lowell Hart, Sibel Blau, Tara Sanft, Meghan Karuturi, Denise A. Yardley, Amelia Zelnak, Amy S. Clark, Angela DeMichele, Sara A. Hurvitz, Aditya Bardia

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f79162e403f52cd2827f8f30f5dab00
https://doi.org/10.1158/1078-0432.22480703.v1

View record in OpenAIRE

20

Data from MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2− Metastatic Breast Cancer

المؤلفون: José Baselga, Andrew Koustenis, Martin Frenzel, Denise A. Yardley, Esther Zamora, Joyce O'Shaughnessy, Clifford A. Hudis, Hans Wildiers, Debra Patt, Véronique Diéras, Javier Cortés, Hope S. Rugo, Sara M. Tolaney, Maura N. Dickler

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::034b8161c60a47be698f6b30bb02f65c
https://doi.org/10.1158/1078-0432.c.6526920

View record in OpenAIRE

تنقيح النتائج